AlphaYouPW
Insider selling
Pamela Wapnick sold $2K of Metagenomi Therapeutics, Inc. (MGX) stock
Pamela Wapnick, Chief Financial Officer of Metagenomi Therapeutics, Inc. (MGX), sold 1,911 shares of MGX stock worth $2K, per an SEC Form 4 filed Sep 10, 2026.
It was an open-market sale.
The trade happened on Sep 8, 2026, 2 days before it was made public.
MGX has moved -3.4% since the trade date, from $1.16 to $1.12 (Sep 21, 2026 close).
- Traded
- Sep 8, 2026
- Disclosed
- Sep 10, 2026
- Filing delay
- 2 days
- Price since
- -3.4%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More MGX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.